| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/19/2002 | CA2440158A1 Method to obtain microparticles containing a h+, k+-atp-ase inhibitor |
| 09/19/2002 | CA2439637A1 Human serpin polypeptides |
| 09/19/2002 | CA2438164A1 Use of preparations containing selenite or selenate |
| 09/19/2002 | CA2437963A1 Therapeutic binding molecules |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/18/2002 | EP1241254A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 09/18/2002 | EP1241170A2 Pyrazolopyrimidine derivatives |
| 09/18/2002 | EP1240335A2 Proteases |
| 09/18/2002 | EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/18/2002 | EP1240212A1 Crosslinked copolymers based on non-crosslinked polycarboxylic copolymers |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240191A1 P. gingivalis antigenic composition |
| 09/18/2002 | EP1240172A1 New aminopropylphosphinic acids |
| 09/18/2002 | EP1240171A1 Cyclopenteneone derivatives |
| 09/18/2002 | EP1240166A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240165A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240164A1 Benzazole derivatives and their use as jnk modulators |
| 09/18/2002 | EP1240160A1 Substituted pyridazines having cytokine inhibitory activity |
| 09/18/2002 | EP1240159A1 Improved omeprazole process and compositions thereof |
| 09/18/2002 | EP1240153A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 09/18/2002 | EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 09/18/2002 | EP1240146A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
| 09/18/2002 | EP1240145A2 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 09/18/2002 | EP1240136A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease |
| 09/18/2002 | EP1239922A2 Treatment of excessive bone or cartilage loss with an activator of ror alpha and assay for identifying such activator |
| 09/18/2002 | EP1239883A2 Formulations of adenosine a1 agonists |
| 09/18/2002 | EP1239881A2 Formulations of adenosine a1 agonists |
| 09/18/2002 | EP1239880A2 Formulations of adenosine a1 agonists |
| 09/18/2002 | EP1239875A1 Procedure to use staphylococcal bacteria |
| 09/18/2002 | EP1239872A2 Enzyme treatment for infection |
| 09/18/2002 | EP1239867A2 Methods for treating and preventing damage to mucosal tissue |
| 09/18/2002 | EP1239845A2 Hydroxide-releasing agents as skin permeation enhancers |
| 09/18/2002 | EP1239843A1 New (aminopropyl)methylphosphinic acids |
| 09/18/2002 | EP1239765A1 Ingestible device for the release of substances at distinct locations in the alimentary canal |
| 09/18/2002 | EP1117633B1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 09/18/2002 | EP1093380B1 Component b as angiogenic agent in combination with human growth factors |
| 09/18/2002 | EP1073408B1 Desensitizing dentifrice containing potassium and tin salts |
| 09/18/2002 | EP1000034B1 Substituted 6-alkylphenanthridines |
| 09/18/2002 | EP0934259B1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/18/2002 | EP0929516B1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 09/18/2002 | EP0910388B1 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease |
| 09/18/2002 | EP0904260B1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids |
| 09/18/2002 | EP0842161B1 4,5-diaryl oxazole derivatives |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/18/2002 | EP0767793B1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370181A Effectors of dipeptidyl peptidase IV for topical use |
| 09/18/2002 | CN1370176A Subsstituted heterocycle fused gamma-carbolines |
| 09/18/2002 | CN1370175A Dithiepino [6,5-b] pyridines, and related compsns. and methods |
| 09/18/2002 | CN1370174A 2,3-benzodiazepine derivatives |
| 09/18/2002 | CN1370172A Optically active pyrrolopyridazine compound |
| 09/18/2002 | CN1370169A Substituted heterocycle fused gamma-carbolines |
| 09/18/2002 | CN1370159A Indole derivatives and their use for treatment of osteoporosis amongst other applications |
| 09/18/2002 | CN1370154A Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/18/2002 | CN1370143A Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 09/18/2002 | CN1370133A Polytype Mg-Al hydrotalcite |
| 09/18/2002 | CN1370080A NSAID and EFGR kinase inhibitor contg. compsn. for treatment or inhibition of colonic polyps and colorectal cancer |
| 09/18/2002 | CN1370068A Pharmaceutical agent comprising benzamide derivative as active ingredient |
| 09/18/2002 | CN1370064A synergistic antibacterial combination |
| 09/18/2002 | CN1369491A Chiral pantorazole salt and its preparing process |
| 09/18/2002 | CN1369307A Composite Chinese medicine for treating heptic fibrosis and cirrhosis due to hepatitis B and its mfg. method |
| 09/18/2002 | CN1369288A 'Jinma Zaishengqixue bao' a medicine for regenerating Qi and blood |
| 09/18/2002 | CN1369282A Oral liquid Chinese medicine immersed in wine |
| 09/18/2002 | CN1369281A Chinese medicine for detoxicating intestine and its preparing process |
| 09/18/2002 | CN1369279A 'Qiangjin Zhuanggu' pill and its preparing process |
| 09/18/2002 | CN1091150C Mortierella Diding CGMCC0346, its isolation cultivation method and fermentation tech method |
| 09/18/2002 | CN1090965C Compounding of Biannaitong tea as laxative and its preparing process |
| 09/18/2002 | CN1090958C Chinese patent medicine for treating peptide ulcer |
| 09/18/2002 | CN1090957C Navel plaster for treating stomach diseases |
| 09/18/2002 | CN1090956C Tibetan pill for treating cholecytitis and gallstones, and method for preparing same |
| 09/18/2002 | CN1090954C 胃炎胶囊 Gastritis Capsules |
| 09/18/2002 | CN1090952C Medicine for treating hepatopostema and its prepn. method |
| 09/18/2002 | CN1090951C Traditional Chinese medicine for curing gastrointestinal disease |
| 09/18/2002 | CN1090946C Health medicine for tonifying spleen and removing dampness heat |
| 09/18/2002 | CN1090918C Silicone compsns. |
| 09/17/2002 | US6452013 For treating conditions which are related to impairment of gastric emptying |
| 09/17/2002 | US6452001 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 09/17/2002 | US6451860 Methods for treating depression and other disorders using optically pure (−)-bupropion |
| 09/17/2002 | US6451859 C16 unsaturated FP-selective prostaglandins analogs |
| 09/17/2002 | US6451849 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |
| 09/17/2002 | US6451839 Indole sPLA2 inhibitors |
| 09/17/2002 | US6451838 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/17/2002 | US6451834 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 09/17/2002 | US6451810 Amide substituted imidazoquinolines |
| 09/17/2002 | US6451808 Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists |
| 09/17/2002 | US6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles |
| 09/17/2002 | US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders |
| 09/17/2002 | US6451801 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 09/17/2002 | US6451794 2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2(COX-2) inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451781 Substituted acylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 09/17/2002 | US6451584 Nutrient broth for use in the propagation of preferential microorgansim and generation of foods |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | CA2260007C Method for treating gastrointestinal damage |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2187908C Non-splicing variants of gp350/220 |
| 09/16/2002 | CA2376844A1 Pyrazolo¢4,3-d!pyrimidin-7-ones and pyrazolo¢3,4!pyrimidin-4-ones and purinones which inhibit cgmp pdes |